Nixxy Appoints AI and MedTech Pioneer Ashissh Raichura to Board of Directors to Advance Secure, Compliant AI Infrastructure
Nixxy (NASDAQ:NIXX) has appointed AI and MedTech pioneer Ashissh Raichura to its Board of Directors, effective immediately. Raichura, who holds dual Ph.D.s in Cloud Computing and Machine Learning, brings over 30 years of experience in secure, compliant platforms across healthcare, telecom, and fintech sectors.
As Founder and CEO of Scanbo, a MedTech company specializing in biosensor AI diagnostics, Raichura has demonstrated expertise in implementing SOC 2, GDPR, and HIPAA-compliant AI platforms. His background includes significant contributions at Tech Mahindra, where he worked on British Telecom's IP infrastructure transition.
The appointment aligns with Nixxy's focus on developing intelligent infrastructure for compliance-intensive industries, leveraging Raichura's expertise in cybersecurity, regulatory compliance, and AI architecture across multiple global markets.
Nixxy (NASDAQ:NIXX) ha nominato il pioniere dell'IA e della tecnologia medica Ashissh Raichura nel suo Consiglio di Amministrazione, con effetto immediato. Raichura, che possiede doppio dottorato in Cloud Computing e Machine Learning, porta con sé oltre 30 anni di esperienza in piattaforme sicure e conformi nei settori della sanità, telecomunicazioni e fintech.
In qualità di Fondatore e CEO di Scanbo, un'azienda MedTech specializzata in diagnosi AI tramite biosensori, Raichura ha dimostrato competenza nell'implementazione di piattaforme AI conformi a SOC 2, GDPR e HIPAA. Il suo background include contributi significativi presso Tech Mahindra, dove ha lavorato sulla transizione dell'infrastruttura IP di British Telecom.
La nomina è in linea con l'obiettivo di Nixxy di sviluppare infrastrutture intelligenti per settori ad alta intensità di conformità, sfruttando l'esperienza di Raichura in cybersecurity, conformità normativa e architettura AI in diversi mercati globali.
Nixxy (NASDAQ:NIXX) ha nombrado al pionero en IA y MedTech Ashissh Raichura en su Junta Directiva, con efecto inmediato. Raichura, que posee dos doctorados en Computación en la Nube y Aprendizaje Automático, aporta más de 30 años de experiencia en plataformas seguras y conformes en los sectores de salud, telecomunicaciones y fintech.
Como fundador y CEO de Scanbo, una empresa de MedTech especializada en diagnósticos de IA mediante biosensores, Raichura ha demostrado su experiencia en la implementación de plataformas de IA que cumplen con SOC 2, GDPR y HIPAA. Su trayectoria incluye contribuciones significativas en Tech Mahindra, donde trabajó en la transición de la infraestructura IP de British Telecom.
El nombramiento está alineado con el enfoque de Nixxy en desarrollar infraestructura inteligente para industrias con alta intensidad de cumplimiento, aprovechando la experiencia de Raichura en ciberseguridad, cumplimiento regulatorio y arquitectura de IA en múltiples mercados globales.
Nixxy (NASDAQ:NIXX)는 AI 및 MedTech의 선구자 Ashissh Raichura를 이사회의 일원으로 즉시 임명했습니다. Raichura는 클라우드 컴퓨팅과 머신 러닝 분야에서 두 개의 박사 학위를 보유하고 있으며, 의료, 통신 및 핀테크 분야에서 안전하고 규정을 준수하는 플랫폼에 대한 30년 이상의 경험을 가지고 있습니다.
MedTech 회사인 Scanbo의 창립자이자 CEO인 Raichura는 바이오센서 AI 진단에 특화된 분야에서 SOC 2, GDPR 및 HIPAA 준수 AI 플랫폼을 구현하는 전문성을 보여주었습니다. 그의 경력에는 British Telecom의 IP 인프라 전환에 참여한 Tech Mahindra에서의 중요한 기여가 포함됩니다.
이번 임명은 Nixxy가 규정 준수가 중요한 산업을 위한 지능형 인프라 개발에 집중하고 있으며, Raichura의 사이버 보안, 규제 준수 및 AI 아키텍처 전문성을 활용하고 있음을 반영합니다.
Nixxy (NASDAQ:NIXX) a nommé le pionnier de l'IA et de la MedTech Ashissh Raichura au sein de son Conseil d'Administration, avec effet immédiat. Raichura, titulaire de deux doctorats en informatique en nuage et apprentissage automatique, apporte plus de 30 ans d'expérience dans des plateformes sécurisées et conformes dans les secteurs de la santé, des télécommunications et de la fintech.
En tant que fondateur et PDG de Scanbo, une entreprise de MedTech spécialisée dans les diagnostics IA via des biosenseurs, Raichura a démontré son expertise dans la mise en œuvre de plateformes IA conformes aux normes SOC 2, GDPR et HIPAA. Son parcours inclut des contributions significatives chez Tech Mahindra, où il a travaillé sur la transition de l'infrastructure IP de British Telecom.
Cette nomination s'inscrit dans l'objectif de Nixxy de développer une infrastructure intelligente pour des industries à forte intensité de conformité, en tirant parti de l'expertise de Raichura en cybersécurité, conformité réglementaire et architecture IA sur plusieurs marchés mondiaux.
Nixxy (NASDAQ:NIXX) hat den Pionier der KI und MedTech Ashissh Raichura mit sofortiger Wirkung in seinen Vorstand berufen. Raichura, der über zwei Doktortitel in Cloud Computing und Machine Learning verfügt, bringt mehr als 30 Jahre Erfahrung in sicheren und konformen Plattformen in den Bereichen Gesundheitswesen, Telekommunikation und Fintech mit.
Als Gründer und CEO von Scanbo, einem MedTech-Unternehmen, das sich auf KI-Diagnosen mit Biosensoren spezialisiert hat, hat Raichura seine Expertise bei der Implementierung von SOC 2-, GDPR- und HIPAA-konformen KI-Plattformen unter Beweis gestellt. Sein Hintergrund umfasst bedeutende Beiträge bei Tech Mahindra, wo er an der Umstellung der IP-Infrastruktur von British Telecom gearbeitet hat.
Die Ernennung steht im Einklang mit Nixxys Fokus auf die Entwicklung intelligenter Infrastrukturen für compliance-intensive Branchen und nutzt Raichuras Expertise in Cybersicherheit, regulatorischer Compliance und KI-Architektur in mehreren globalen Märkten.
- Appointment of highly qualified board member with dual Ph.D.s and 30+ years of relevant industry experience
- Strategic addition of expertise in critical areas: AI infrastructure, regulatory compliance, and healthcare technology
- Enhanced capability in implementing SOC 2, GDPR, and HIPAA compliance frameworks
- None.
Renowned AI technologist with dual Ph.D.s in Cloud Computing and Machine Learning joins Nixxy board
Founder of Scanbo and expert in real-time, non-invasive diagnostics powered by biosensor AI
30+ years leading secure, compliant platforms across healthcare, telecom, and fintech
Proven experience in SOC 2, GDPR, HIPAA, and end-to-end AI security frameworks
NEW YORK, NY / ACCESS Newswire / April 7, 2025 / Nixxy, Inc. (NASDAQ:NIXX), an AI-first technology company transforming compliance-intensive industries with intelligent infrastructure, today announced the appointment of Ashissh Raichura to its Board of Directors, effective immediately.
Raichura is a globally respected AI technologist and entrepreneur with three decades of experience building intelligent, secure platforms at scale. He holds dual Ph.D.s in Cloud Computing and Artificial Intelligence/Machine Learning, and is the Founder and CEO of Scanbo, a next-generation MedTech and medical device company delivering real-time, non-invasive diagnostics using biosensor AI. His work is at the intersection of healthcare, diagnostics, and intelligent infrastructure, with a focus on delivering clinically impactful, compliant, and accessible solutions.
"Ashissh combines rare depth in both AI architecture and global compliance strategy," said Miles Jennings, Interim CEO of Nixxy. "His leadership in building SOC 2, GDPR, and HIPAA-compliant AI platforms, especially in healthcare and MedTech, will be instrumental as we grow Nixxy's infrastructure across mission-critical industries."
Over his three-decade career, Raichura has launched and scaled enterprise-grade AI and diagnostic platforms across North America, India, and Latin America. His work spans AI integration in healthcare delivery, medical diagnostics, MedTech innovation, telecom, and e-government-environments where security, resilience, and regulatory compliance are foundational.
Earlier in his career, Raichura worked at Tech Mahindra, where he contributed to a major British Telecom project as part of the solution design team. He played a key role in helping BT transition to an IP-based infrastructure-an early example of his capabilities in modernizing legacy telecom systems for the digital age.
At Scanbo, Raichura led the development of cloud-native medical systems built from the ground up with data privacy, patient safety, and regulatory alignment at the core. Under his leadership, Scanbo successfully implemented SOC 2 audits, HIPAA-aligned protocols, GDPR safeguards, and end-to-end encryption (including SEC 2014-grade storage protection). He has also overseen multi-layer cybersecurity frameworks, including VAPT certifications, across both mobile and cloud-based diagnostic platforms.
"Nixxy recognizes that building trustworthy AI requires prioritizing scalability, regulatory alignment, and real-world impact," said Raichura. "I'm excited to contribute to a company that understands AI's true potential to advance sectors like healthcare and telecom, while upholding the highest standards of trust, safety, and impact."
Multilingual and globally experienced in AI and MedTech, Raichura brings a cross-border perspective to Nixxy's board. His advanced certifications in IoT and cybersecurity compliance align seamlessly with Nixxy's long-term vision.
About Nixxy, Inc.
Nixxy, Inc. (NASDAQ: NIXX) is an AI-first technology company transforming fragmented, legacy systems into intelligent, secure platforms. With a focus on AI-powered communications, infrastructure, and compliance, Nixxy builds the digital spine for industries like healthcare, telecom, and government. Its flagship platform, Auralink AI, delivers secure CPaaS, AI billing, and enterprise infrastructure aligned with the strictest regulatory standards. Learn more at https://www.nixxy.com.
Forward-Looking Statements Disclaimer
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, including, but not limited to, those regarding the Company's business strategy, future operations, acquisition strategy, financial position, potential growth, spin-out transactions, and market opportunities.
Forward-looking statements are based on current expectations, estimates, and projections, and involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied. These risks and uncertainties include, but are not limited to, market conditions, business execution, integration of new assets, regulatory developments, and other risk factors described in the Company's filings with the Securities and Exchange Commission, including its most recent reports on Form 10-K and Form 10-Q.
Words such as "anticipates," "believes," "expects," "intends," "plans," "may," "will," and similar expressions are intended to identify forward-looking statements, but the absence of these words does not mean a statement is not forward-looking.
Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
No Offer or Solicitation Disclaimer
This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
Risk Factors
Investors should carefully consider the risks, uncertainties, and assumptions associated with the Company's business, including the execution risks related to entering a new line of business and integrating recently acquired software. The Company currently has no revenue from the telecommunications line of business, and its ability to generate revenue and achieve profitability in this area depends on the successful execution of its business strategy, including the commercialization of its newly acquired technology, customer adoption, and operational scaling. There is no guarantee that the Company will be able to effectively integrate the acquired software, develop a viable market for its offerings, or realize anticipated synergies. The Company also faces risks related to market conditions, competition, evolving industry standards, and regulatory developments, which could impact its growth prospects. Additionally, the planned spin-out transaction involves uncertainties regarding timing, regulatory approvals, and overall market reception. Financial and liquidity risks, including the availability of capital and access to financing, may also affect the Company's ability to support this business expansion. These and other risks are detailed in the Company's filings with the U.S. Securities and Exchange Commission, including its most recent reports on Form 10-K and Form 10-Q. Actual results may differ materially due to known and unknown factors, and investors are urged to review the Company's SEC filings and conduct their own due diligence before making investment decisions.
Investor Contact:
Nixxy, Inc. Investor Relations
Email: IR@nixxy.com
Phone: (877) 708-8868
SOURCE: Nixxy, Inc.
View the original press release on ACCESS Newswire
FAQ
What expertise does Ashissh Raichura bring to Nixxy's board?
How does Raichura's appointment align with Nixxy's business strategy?
What is Ashissh Raichura's background in healthcare technology?
What regulatory compliance expertise does Raichura bring to NIXX?
